Literature DB >> 6344713

Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention.

L Corey, K K Holmes.   

Abstract

Genital herpes simplex virus infection is the commonest cause of genital ulcerations in persons in industrialized nations. Overlap in the clinical manifestations of genital herpes with other infectious and noninfectious causes of genital ulcerations often requires clinicians to seek laboratory confirmation of the cause of a genital ulcer. The sensitivity of any laboratory procedure for detecting herpes simplex virus infection differs with the stage of the disease. Isolation of the herpes simplex virus in tissue culture is the most sensitive and specific laboratory test for the confirmation of genital herpes; cytologic and antigen detection techniques are approximately 50% and 70% as sensitive as viral isolation. The antiviral compound acyclovir is the first medication useful for the management of persons with genital herpes. Prevention of transmission of infection and recurrences of disease, however, has not been achieved. Description of the clinical manifestations of disease, its variable recurrence rate, and potential for future infectivity are issues that physicians should discuss with patients who have genital herpes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6344713     DOI: 10.7326/0003-4819-98-6-973

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  37 in total

1.  Diagnosis of genital herpes by real time PCR in routine clinical practice.

Authors:  M Ramaswamy; C McDonald; M Smith; D Thomas; S Maxwell; M Tenant-Flowers; A M Geretti
Journal:  Sex Transm Infect       Date:  2004-10       Impact factor: 3.519

Review 2.  Role of Marine Natural Products in the Genesis of Antiviral Agents.

Authors:  Vedanjali Gogineni; Raymond F Schinazi; Mark T Hamann
Journal:  Chem Rev       Date:  2015-08-28       Impact factor: 60.622

3.  Genital herpes.

Authors:  A M Geretti
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

4.  In Vitro and In Vivo Activity, Tolerability, and Mechanism of Action of BX795 as an Antiviral against Herpes Simplex Virus 2 Genital Infection.

Authors:  James Hopkins; Tejabhiram Yadavalli; Rahul Suryawanshi; Farreh Qatanani; Ipsita Volety; Ram Koganti; Aqsa Iqbal; Deepak Shukla
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

5.  Toward the rational management of herpes infection in pregnant women and their newborn infants. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.

Authors: 
Journal:  CMAJ       Date:  1992-05-01       Impact factor: 8.262

6.  Genital herpes.

Authors:  F P Scappatura
Journal:  Can Fam Physician       Date:  1987-08       Impact factor: 3.275

7.  Vaginal discharge: an approach to diagnosis and management.

Authors:  W J Watson; G Demarchi
Journal:  Can Fam Physician       Date:  1987-08       Impact factor: 3.275

8.  The office management of sexually transmitted diseases.

Authors:  F S Crombie
Journal:  Can Fam Physician       Date:  1987-08       Impact factor: 3.275

9.  Detection and direct typing of herpes simplex virus in perianal ulcers of patients with AIDS by PCR.

Authors:  M C do Nascimento; L M Sumita; V A de Souza; C S Pannuti
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

10.  Oral shedding of herpes simplex virus type 2.

Authors:  A Wald; M Ericsson; E Krantz; S Selke; L Corey
Journal:  Sex Transm Infect       Date:  2004-08       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.